{"id":1339,"date":"2019-09-14T13:24:08","date_gmt":"2019-09-14T13:24:08","guid":{"rendered":"https:\/\/blogs.bmj.com\/jmg\/?p=1339"},"modified":"2026-02-24T00:27:24","modified_gmt":"2026-02-24T00:27:24","slug":"rapid-proteomic-urine-assay-for-monitoring-progressive-organ-disease-in-fabry-disease","status":"publish","type":"post","link":"https:\/\/blogs.bmj.com\/jmg\/2019\/09\/14\/rapid-proteomic-urine-assay-for-monitoring-progressive-organ-disease-in-fabry-disease\/","title":{"rendered":"Rapid, proteomic urine assay for monitoring progressive organ disease in Fabry disease (Contributed by Dr Kevin Mills)"},"content":{"rendered":"<p>This works describes a new and non-invasive way to simultaneously monitor an inflammatory response, lysosomal dysfunction, kidney and cardiovascular disease.\u00a0 Fabry Disease is a condition where we cannot breakdown a glycolipid.\u00a0 This builds up in the body causing kidney and\/or cardiovascular damage. Plasma lyso-Gb3 is the general lipid biomarker used to monitor response to treatment but it does not tell us anything about what organs are affected or which systems are responding. Our simple, 10-minute, targeted proteomic urine test measures many biomarkers at once and allows us to monitor organ damage without the need for invasive or time consuming procedures. (<a href=\"https:\/\/jmg.bmj.com\/content\/early\/2019\/09\/12\/jmedgenet-2019-106030\">https:\/\/jmg.bmj.com\/content\/early\/2019\/09\/12\/jmedgenet-2019-106030<\/a> )<\/p>\n<p><a href=\"https:\/\/blogs.bmj.com\/jmg\/2019\/09\/14\/rapid-proteomic-urine-assay-for-monitoring-progressive-organ-disease-in-fabry-disease\/26543510563_7b11d59f3f_o\/\" rel=\"attachment wp-att-1340\"><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-medium wp-image-1340\" src=\"https:\/\/blogs.bmj.com\/jmg\/files\/2019\/09\/26543510563_7b11d59f3f_o-300x173.jpg\" alt=\"\" width=\"300\" height=\"173\" srcset=\"https:\/\/blogs.bmj.com\/jmg\/files\/2019\/09\/26543510563_7b11d59f3f_o-300x173.jpg 300w, https:\/\/blogs.bmj.com\/jmg\/files\/2019\/09\/26543510563_7b11d59f3f_o-768x442.jpg 768w, https:\/\/blogs.bmj.com\/jmg\/files\/2019\/09\/26543510563_7b11d59f3f_o-1024x590.jpg 1024w, https:\/\/blogs.bmj.com\/jmg\/files\/2019\/09\/26543510563_7b11d59f3f_o-640x369.jpg 640w, https:\/\/blogs.bmj.com\/jmg\/files\/2019\/09\/26543510563_7b11d59f3f_o.jpg 1959w\" sizes=\"auto, (max-width: 300px) 100vw, 300px\" \/><\/a><a href=\"https:\/\/blogs.bmj.com\/jmg\/2019\/09\/14\/rapid-proteomic-urine-assay-for-monitoring-progressive-organ-disease-in-fabry-disease\/39827044802_17c5445f04_o\/\" rel=\"attachment wp-att-1341\"><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-medium wp-image-1341\" src=\"https:\/\/blogs.bmj.com\/jmg\/files\/2019\/09\/39827044802_17c5445f04_o-300x118.jpg\" alt=\"\" width=\"300\" height=\"118\" srcset=\"https:\/\/blogs.bmj.com\/jmg\/files\/2019\/09\/39827044802_17c5445f04_o-300x118.jpg 300w, https:\/\/blogs.bmj.com\/jmg\/files\/2019\/09\/39827044802_17c5445f04_o-768x302.jpg 768w, https:\/\/blogs.bmj.com\/jmg\/files\/2019\/09\/39827044802_17c5445f04_o-1024x402.jpg 1024w, https:\/\/blogs.bmj.com\/jmg\/files\/2019\/09\/39827044802_17c5445f04_o-640x251.jpg 640w\" sizes=\"auto, (max-width: 300px) 100vw, 300px\" \/><\/a><!--TrendMD v2.4.8--><\/p>\n","protected":false},"excerpt":{"rendered":"<p>This works describes a new and non-invasive way to simultaneously monitor an inflammatory response, lysosomal dysfunction, kidney and cardiovascular disease.\u00a0 Fabry Disease is a condition where we cannot breakdown a glycolipid.\u00a0 This builds up in the body causing kidney and\/or cardiovascular damage. Plasma lyso-Gb3 is the general lipid biomarker used to monitor response to treatment [&#8230;]<\/p>\n<p><a class=\"btn btn-secondary understrap-read-more-link\" href=\"https:\/\/blogs.bmj.com\/jmg\/2019\/09\/14\/rapid-proteomic-urine-assay-for-monitoring-progressive-organ-disease-in-fabry-disease\/\">Read More&#8230;<\/a><\/p>\n","protected":false},"author":123,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-1339","post","type-post","status-publish","format-standard","hentry","category-uncategorized"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Rapid, proteomic urine assay for monitoring progressive organ disease in Fabry disease (Contributed by Dr Kevin Mills) - JMG Contact blog<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/blogs.bmj.com\/jmg\/2019\/09\/14\/rapid-proteomic-urine-assay-for-monitoring-progressive-organ-disease-in-fabry-disease\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Rapid, proteomic urine assay for monitoring progressive organ disease in Fabry disease (Contributed by Dr Kevin Mills) - JMG Contact blog\" \/>\n<meta property=\"og:description\" content=\"This works describes a new and non-invasive way to simultaneously monitor an inflammatory response, lysosomal dysfunction, kidney and cardiovascular disease.\u00a0 Fabry Disease is a condition where we cannot breakdown a glycolipid.\u00a0 This builds up in the body causing kidney and\/or cardiovascular damage. Plasma lyso-Gb3 is the general lipid biomarker used to monitor response to treatment [...]Read More...\" \/>\n<meta property=\"og:url\" content=\"https:\/\/blogs.bmj.com\/jmg\/2019\/09\/14\/rapid-proteomic-urine-assay-for-monitoring-progressive-organ-disease-in-fabry-disease\/\" \/>\n<meta property=\"og:site_name\" content=\"JMG Contact blog\" \/>\n<meta property=\"article:published_time\" content=\"2019-09-14T13:24:08+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-02-24T00:27:24+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/blogs.bmj.com\/jmg\/files\/2019\/09\/26543510563_7b11d59f3f_o.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1959\" \/>\n\t<meta property=\"og:image:height\" content=\"1128\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"hqqu\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@HuiQiQu\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"hqqu\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/2019\\\/09\\\/14\\\/rapid-proteomic-urine-assay-for-monitoring-progressive-organ-disease-in-fabry-disease\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/2019\\\/09\\\/14\\\/rapid-proteomic-urine-assay-for-monitoring-progressive-organ-disease-in-fabry-disease\\\/\"},\"author\":{\"name\":\"hqqu\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/#\\\/schema\\\/person\\\/be0250f8d5b52412c3e7c222dabd591b\"},\"headline\":\"Rapid, proteomic urine assay for monitoring progressive organ disease in Fabry disease (Contributed by Dr Kevin Mills)\",\"datePublished\":\"2019-09-14T13:24:08+00:00\",\"dateModified\":\"2026-02-24T00:27:24+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/2019\\\/09\\\/14\\\/rapid-proteomic-urine-assay-for-monitoring-progressive-organ-disease-in-fabry-disease\\\/\"},\"wordCount\":126,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/2019\\\/09\\\/14\\\/rapid-proteomic-urine-assay-for-monitoring-progressive-organ-disease-in-fabry-disease\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/files\\\/2019\\\/09\\\/26543510563_7b11d59f3f_o-300x173.jpg\",\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/2019\\\/09\\\/14\\\/rapid-proteomic-urine-assay-for-monitoring-progressive-organ-disease-in-fabry-disease\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/2019\\\/09\\\/14\\\/rapid-proteomic-urine-assay-for-monitoring-progressive-organ-disease-in-fabry-disease\\\/\",\"url\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/2019\\\/09\\\/14\\\/rapid-proteomic-urine-assay-for-monitoring-progressive-organ-disease-in-fabry-disease\\\/\",\"name\":\"Rapid, proteomic urine assay for monitoring progressive organ disease in Fabry disease (Contributed by Dr Kevin Mills) - JMG Contact blog\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/2019\\\/09\\\/14\\\/rapid-proteomic-urine-assay-for-monitoring-progressive-organ-disease-in-fabry-disease\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/2019\\\/09\\\/14\\\/rapid-proteomic-urine-assay-for-monitoring-progressive-organ-disease-in-fabry-disease\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/files\\\/2019\\\/09\\\/26543510563_7b11d59f3f_o-300x173.jpg\",\"datePublished\":\"2019-09-14T13:24:08+00:00\",\"dateModified\":\"2026-02-24T00:27:24+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/2019\\\/09\\\/14\\\/rapid-proteomic-urine-assay-for-monitoring-progressive-organ-disease-in-fabry-disease\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/2019\\\/09\\\/14\\\/rapid-proteomic-urine-assay-for-monitoring-progressive-organ-disease-in-fabry-disease\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/2019\\\/09\\\/14\\\/rapid-proteomic-urine-assay-for-monitoring-progressive-organ-disease-in-fabry-disease\\\/#primaryimage\",\"url\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/files\\\/2019\\\/09\\\/26543510563_7b11d59f3f_o.jpg\",\"contentUrl\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/files\\\/2019\\\/09\\\/26543510563_7b11d59f3f_o.jpg\",\"width\":1959,\"height\":1128},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/2019\\\/09\\\/14\\\/rapid-proteomic-urine-assay-for-monitoring-progressive-organ-disease-in-fabry-disease\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Rapid, proteomic urine assay for monitoring progressive organ disease in Fabry disease (Contributed by Dr Kevin Mills)\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/#website\",\"url\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/\",\"name\":\"JMG Contact blog\",\"description\":\"JMG Contact blog\",\"publisher\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/#organization\",\"name\":\"JMG Contact blog\",\"url\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/files\\\/2017\\\/10\\\/blog-logo-jmg.png\",\"contentUrl\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/files\\\/2017\\\/10\\\/blog-logo-jmg.png\",\"width\":300,\"height\":34,\"caption\":\"JMG Contact blog\"},\"image\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/#\\\/schema\\\/person\\\/be0250f8d5b52412c3e7c222dabd591b\",\"name\":\"hqqu\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/920bc4e81500cde88def4bfd7775029cb154e422c5460b9cf80d5c47137d6f35?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/920bc4e81500cde88def4bfd7775029cb154e422c5460b9cf80d5c47137d6f35?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/920bc4e81500cde88def4bfd7775029cb154e422c5460b9cf80d5c47137d6f35?s=96&d=mm&r=g\",\"caption\":\"hqqu\"},\"description\":\"Huiqi Qu has a background as a physician trained in internal medicine and a PhD in Experimental Medicine (Endocrinology). His research applies human genetics and multi-omics to complex and pediatric diseases, including GWAS, polygenic risk scores (PRS), single-cell transcriptomics, and integrative genomics to support precision medicine and clinical translation.\",\"sameAs\":[\"https:\\\/\\\/x.com\\\/HuiQiQu\"],\"url\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/author\\\/hqiqu\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Rapid, proteomic urine assay for monitoring progressive organ disease in Fabry disease (Contributed by Dr Kevin Mills) - JMG Contact blog","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/blogs.bmj.com\/jmg\/2019\/09\/14\/rapid-proteomic-urine-assay-for-monitoring-progressive-organ-disease-in-fabry-disease\/","og_locale":"en_US","og_type":"article","og_title":"Rapid, proteomic urine assay for monitoring progressive organ disease in Fabry disease (Contributed by Dr Kevin Mills) - JMG Contact blog","og_description":"This works describes a new and non-invasive way to simultaneously monitor an inflammatory response, lysosomal dysfunction, kidney and cardiovascular disease.\u00a0 Fabry Disease is a condition where we cannot breakdown a glycolipid.\u00a0 This builds up in the body causing kidney and\/or cardiovascular damage. Plasma lyso-Gb3 is the general lipid biomarker used to monitor response to treatment [...]Read More...","og_url":"https:\/\/blogs.bmj.com\/jmg\/2019\/09\/14\/rapid-proteomic-urine-assay-for-monitoring-progressive-organ-disease-in-fabry-disease\/","og_site_name":"JMG Contact blog","article_published_time":"2019-09-14T13:24:08+00:00","article_modified_time":"2026-02-24T00:27:24+00:00","og_image":[{"width":1959,"height":1128,"url":"https:\/\/blogs.bmj.com\/jmg\/files\/2019\/09\/26543510563_7b11d59f3f_o.jpg","type":"image\/jpeg"}],"author":"hqqu","twitter_card":"summary_large_image","twitter_creator":"@HuiQiQu","twitter_misc":{"Written by":"hqqu","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/blogs.bmj.com\/jmg\/2019\/09\/14\/rapid-proteomic-urine-assay-for-monitoring-progressive-organ-disease-in-fabry-disease\/#article","isPartOf":{"@id":"https:\/\/blogs.bmj.com\/jmg\/2019\/09\/14\/rapid-proteomic-urine-assay-for-monitoring-progressive-organ-disease-in-fabry-disease\/"},"author":{"name":"hqqu","@id":"https:\/\/blogs.bmj.com\/jmg\/#\/schema\/person\/be0250f8d5b52412c3e7c222dabd591b"},"headline":"Rapid, proteomic urine assay for monitoring progressive organ disease in Fabry disease (Contributed by Dr Kevin Mills)","datePublished":"2019-09-14T13:24:08+00:00","dateModified":"2026-02-24T00:27:24+00:00","mainEntityOfPage":{"@id":"https:\/\/blogs.bmj.com\/jmg\/2019\/09\/14\/rapid-proteomic-urine-assay-for-monitoring-progressive-organ-disease-in-fabry-disease\/"},"wordCount":126,"commentCount":0,"publisher":{"@id":"https:\/\/blogs.bmj.com\/jmg\/#organization"},"image":{"@id":"https:\/\/blogs.bmj.com\/jmg\/2019\/09\/14\/rapid-proteomic-urine-assay-for-monitoring-progressive-organ-disease-in-fabry-disease\/#primaryimage"},"thumbnailUrl":"https:\/\/blogs.bmj.com\/jmg\/files\/2019\/09\/26543510563_7b11d59f3f_o-300x173.jpg","inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/blogs.bmj.com\/jmg\/2019\/09\/14\/rapid-proteomic-urine-assay-for-monitoring-progressive-organ-disease-in-fabry-disease\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/blogs.bmj.com\/jmg\/2019\/09\/14\/rapid-proteomic-urine-assay-for-monitoring-progressive-organ-disease-in-fabry-disease\/","url":"https:\/\/blogs.bmj.com\/jmg\/2019\/09\/14\/rapid-proteomic-urine-assay-for-monitoring-progressive-organ-disease-in-fabry-disease\/","name":"Rapid, proteomic urine assay for monitoring progressive organ disease in Fabry disease (Contributed by Dr Kevin Mills) - JMG Contact blog","isPartOf":{"@id":"https:\/\/blogs.bmj.com\/jmg\/#website"},"primaryImageOfPage":{"@id":"https:\/\/blogs.bmj.com\/jmg\/2019\/09\/14\/rapid-proteomic-urine-assay-for-monitoring-progressive-organ-disease-in-fabry-disease\/#primaryimage"},"image":{"@id":"https:\/\/blogs.bmj.com\/jmg\/2019\/09\/14\/rapid-proteomic-urine-assay-for-monitoring-progressive-organ-disease-in-fabry-disease\/#primaryimage"},"thumbnailUrl":"https:\/\/blogs.bmj.com\/jmg\/files\/2019\/09\/26543510563_7b11d59f3f_o-300x173.jpg","datePublished":"2019-09-14T13:24:08+00:00","dateModified":"2026-02-24T00:27:24+00:00","breadcrumb":{"@id":"https:\/\/blogs.bmj.com\/jmg\/2019\/09\/14\/rapid-proteomic-urine-assay-for-monitoring-progressive-organ-disease-in-fabry-disease\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/blogs.bmj.com\/jmg\/2019\/09\/14\/rapid-proteomic-urine-assay-for-monitoring-progressive-organ-disease-in-fabry-disease\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/blogs.bmj.com\/jmg\/2019\/09\/14\/rapid-proteomic-urine-assay-for-monitoring-progressive-organ-disease-in-fabry-disease\/#primaryimage","url":"https:\/\/blogs.bmj.com\/jmg\/files\/2019\/09\/26543510563_7b11d59f3f_o.jpg","contentUrl":"https:\/\/blogs.bmj.com\/jmg\/files\/2019\/09\/26543510563_7b11d59f3f_o.jpg","width":1959,"height":1128},{"@type":"BreadcrumbList","@id":"https:\/\/blogs.bmj.com\/jmg\/2019\/09\/14\/rapid-proteomic-urine-assay-for-monitoring-progressive-organ-disease-in-fabry-disease\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/blogs.bmj.com\/jmg\/"},{"@type":"ListItem","position":2,"name":"Rapid, proteomic urine assay for monitoring progressive organ disease in Fabry disease (Contributed by Dr Kevin Mills)"}]},{"@type":"WebSite","@id":"https:\/\/blogs.bmj.com\/jmg\/#website","url":"https:\/\/blogs.bmj.com\/jmg\/","name":"JMG Contact blog","description":"JMG Contact blog","publisher":{"@id":"https:\/\/blogs.bmj.com\/jmg\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/blogs.bmj.com\/jmg\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/blogs.bmj.com\/jmg\/#organization","name":"JMG Contact blog","url":"https:\/\/blogs.bmj.com\/jmg\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/blogs.bmj.com\/jmg\/#\/schema\/logo\/image\/","url":"https:\/\/blogs.bmj.com\/jmg\/files\/2017\/10\/blog-logo-jmg.png","contentUrl":"https:\/\/blogs.bmj.com\/jmg\/files\/2017\/10\/blog-logo-jmg.png","width":300,"height":34,"caption":"JMG Contact blog"},"image":{"@id":"https:\/\/blogs.bmj.com\/jmg\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/blogs.bmj.com\/jmg\/#\/schema\/person\/be0250f8d5b52412c3e7c222dabd591b","name":"hqqu","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/920bc4e81500cde88def4bfd7775029cb154e422c5460b9cf80d5c47137d6f35?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/920bc4e81500cde88def4bfd7775029cb154e422c5460b9cf80d5c47137d6f35?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/920bc4e81500cde88def4bfd7775029cb154e422c5460b9cf80d5c47137d6f35?s=96&d=mm&r=g","caption":"hqqu"},"description":"Huiqi Qu has a background as a physician trained in internal medicine and a PhD in Experimental Medicine (Endocrinology). His research applies human genetics and multi-omics to complex and pediatric diseases, including GWAS, polygenic risk scores (PRS), single-cell transcriptomics, and integrative genomics to support precision medicine and clinical translation.","sameAs":["https:\/\/x.com\/HuiQiQu"],"url":"https:\/\/blogs.bmj.com\/jmg\/author\/hqiqu\/"}]}},"_links":{"self":[{"href":"https:\/\/blogs.bmj.com\/jmg\/wp-json\/wp\/v2\/posts\/1339","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/blogs.bmj.com\/jmg\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/blogs.bmj.com\/jmg\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/blogs.bmj.com\/jmg\/wp-json\/wp\/v2\/users\/123"}],"replies":[{"embeddable":true,"href":"https:\/\/blogs.bmj.com\/jmg\/wp-json\/wp\/v2\/comments?post=1339"}],"version-history":[{"count":0,"href":"https:\/\/blogs.bmj.com\/jmg\/wp-json\/wp\/v2\/posts\/1339\/revisions"}],"wp:attachment":[{"href":"https:\/\/blogs.bmj.com\/jmg\/wp-json\/wp\/v2\/media?parent=1339"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/blogs.bmj.com\/jmg\/wp-json\/wp\/v2\/categories?post=1339"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/blogs.bmj.com\/jmg\/wp-json\/wp\/v2\/tags?post=1339"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}